Carlotta Scarpa et al. 2020. The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease. Annali Italiani di Chirurgia. 9, September (Oct. 2020), 1–3.